Untitled Document

3:00 – 3:30pm

Registration & Networking

3:30 – 3:45pm

Welcome and Introduction


Michelle Basil,
Partner, Life Sciences, Nutter

3:45 – 4:10pm

Keynote Speaker


Omar Amirana, MD,
Senior Vice President, Allied Minds

4:10 – 5:00pm

Drugs, Devices and Diagnostics: Will the IPOs, M&As and investments continue?


Panel Discussion Moderator:


Luke Timmerman,
Founder and Editor, Timmerman Report


Panelists include:


Ben Dunn,
Managing Director, Covington Associates


Bryan Giraudo,
Managing Director, Leerink Partners


Paulina Hill,
Principal, Polaris Partners


James Woods,
Principal - Deals, Valuation, PwC

5:00 – 5:10pm


5:10 – 6:00pm

Market Viability: What are the prerequisites for success?


Panel Discussion Moderator:


Jeremy Halpern,
Partner, Emerging Companies, Nutter


Panelists include:


PJ Anand,
Founder, President & CEO, Alcyone Lifesciences


David Donabedian,
Venture Partner, Longwood Fund


Jason Hafler,
Senior Director of Investments and Principal, Sanofi-Genzyme BioVentures

6:00 – 7:00pm